Quince Therapeutics, Inc. (QNCX) financials · $79.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Quince Therapeutics, Inc. (QNCX) $79.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$58.1M | -$57.3M |
| Net Income | -$84.0M | -$56.8M |
| EPS (Diluted) | -$1.68 | -$1.31 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $93.5M | $114.5M |
| Current Assets | $22.9M | $44.0M |
| Cash & Equivalents | $5.81M | $6.21M |
| PP&E | $595.0K | $315.0K |
| Total Liabilities | $129.2M | $84.3M |
| Current Liabilities | $43.2M | $7.28M |
| Short-term Debt | $18.0M | N/A |
| Long-term Debt | N/A | $14.3M |
| Total Debt | $18.0M† | $14.3M† |
| Shareholders' Equity | -$35.7M | $30.1M |
| Retained Earnings | -$460.5M | -$376.5M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$41.4M | -$31.9M |
| CapEx | $352.0K | $257.0K |
| Investing Cash Flow | $23.2M | $21.9M |
| Financing Cash Flow | $17.9M | -$4.78M |
| Net Change in Cash | -$403.0K | -$14.5M |
| Free Cash Flow | -$41.8M | -$32.2M |
FAQ
What is QNCX P/E and revenue?
Quince Therapeutics, Inc. (QNCX) $79.3M cap.
What is QNCX revenue?
QNCX income-statement cache has no revenue figure yet.
Is QNCX profitable?
Quince Therapeutics, Inc. last cached net income is -$84.0M (FY2025).
What are QNCX total assets?
Quince Therapeutics, Inc. last cached total assets are $93.5M (FY2025).
What is QNCX free cash flow?
Quince Therapeutics, Inc. last cached free cash flow is -$41.8M (FY2025).
Not investment advice. Cached statements, not a live tape.